These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Large-scale purification of the F1 antigen of Yersinia pestis. Reddin KM; Easterbrook TJ; Robinson A; Williamson D; Rhind-tutt R Contrib Microbiol Immunol; 1995; 13():329-30. PubMed ID: 8833865 [No Abstract] [Full Text] [Related]
4. Macromolecular organisation of recombinant Yersinia pestis F1 antigen and the effect of structure on immunogenicity. Miller J; Williamson ED; Lakey JH; Pearce MJ; Jones SM; Titball RW FEMS Immunol Med Microbiol; 1998 Jul; 21(3):213-21. PubMed ID: 9718211 [TBL] [Abstract][Full Text] [Related]
5. Ionization and solubility of chitosan solutions related to thermosensitive chitosan/glycerol-phosphate systems. Filion D; Lavertu M; Buschmann MD Biomacromolecules; 2007 Oct; 8(10):3224-34. PubMed ID: 17850110 [TBL] [Abstract][Full Text] [Related]
6. Antigen F1 from Yersinia pestis forms aqueous channels in lipid bilayer membranes. Rodrigues CG; Carneiro CM; Barbosa CT; Nogueira RA Braz J Med Biol Res; 1992; 25(1):75-9. PubMed ID: 1284806 [TBL] [Abstract][Full Text] [Related]
7. Immunochemical localization of the fraction-1 antigen, a virulence determinant of Yersinia pestis. Abath FG; Almeida AM; Ferreira LC An Acad Bras Cienc; 1990 Sep; 62(3):291-7. PubMed ID: 2094179 [TBL] [Abstract][Full Text] [Related]
8. A new purification strategy for fraction 1 capsular antigen and its efficacy against Yersinia pestis virulent strain challenge. Wang T; Qi Z; Wu B; Zhu Z; Yang Y; Cui B; Dai R; Zhang Q; Qiu Y; Wang Z; Wang H; Guo Z; Wang X; Yang R Protein Expr Purif; 2008 Sep; 61(1):7-12. PubMed ID: 18539482 [TBL] [Abstract][Full Text] [Related]
9. Macromolecular organization of the Yersinia pestis capsular F1 antigen: insights from time-of-flight mass spectrometry. Tito MA; Miller J; Griffin KF; Williamson ED; Titball RW; Robinson CV Protein Sci; 2001 Nov; 10(11):2408-13. PubMed ID: 11604546 [TBL] [Abstract][Full Text] [Related]
10. Design and testing for a nontagged F1-V fusion protein as vaccine antigen against bubonic and pneumonic plague. Powell BS; Andrews GP; Enama JT; Jendrek S; Bolt C; Worsham P; Pullen JK; Ribot W; Hines H; Smith L; Heath DG; Adamovicz JJ Biotechnol Prog; 2005; 21(5):1490-510. PubMed ID: 16209555 [TBL] [Abstract][Full Text] [Related]
12. Structure and assembly of Yersinia pestis F1 antigen. Knight SD Adv Exp Med Biol; 2007; 603():74-87. PubMed ID: 17966405 [TBL] [Abstract][Full Text] [Related]
13. Mechanism of formation of amyloid protofibrils of barstar from soluble oligomers: evidence for multiple steps and lateral association coupled to conformational conversion. Kumar S; Mohanty SK; Udgaonkar JB J Mol Biol; 2007 Apr; 367(4):1186-204. PubMed ID: 17292913 [TBL] [Abstract][Full Text] [Related]
14. Construction and characterization of monomeric tryptophan repressor: a model for an early intermediate in the folding of a dimeric protein. Shao X; Hensley P; Matthews CR Biochemistry; 1997 Aug; 36(32):9941-9. PubMed ID: 9245428 [TBL] [Abstract][Full Text] [Related]
15. [Immunochemical characterization of Fraction I of Yersinia pestis strains by CAF1M gene]. Fedorova VA; Devdariani ZL Mol Gen Mikrobiol Virusol; 2002; (1):11-7. PubMed ID: 11904918 [TBL] [Abstract][Full Text] [Related]
16. [The physicochemical and biological characteristics of the Yersinia pestis pH 6 antigen isolated by an immunosorption method]. Stepanshina VN; Gremiakova TA; Anisimov AP; Potapov VD Zh Mikrobiol Epidemiol Immunobiol; 1993; (3):12-7. PubMed ID: 8067083 [TBL] [Abstract][Full Text] [Related]